Roswell Park Team Identifies New Tumor Suppressor Protein in Prostate Cancer
December 02, 2019
December 02, 2019
BUFFALO, New York, Dec. 2 -- The Roswell Park Comprehensive Cancer Center issued the following news release:
* * *
- Study results support development of LRIG1 as novel anti-cancer therapeutic
* * *
A research team led by a scientist at Roswell Park Comprehensive Cancer Center has identified the molecule LRIG1 as an important endogenous tumor suppressor in prostate cancer. Writing in the journal Nature Communications, the team documents their . . .
* * *
- Study results support development of LRIG1 as novel anti-cancer therapeutic
* * *
A research team led by a scientist at Roswell Park Comprehensive Cancer Center has identified the molecule LRIG1 as an important endogenous tumor suppressor in prostate cancer. Writing in the journal Nature Communications, the team documents their . . .